Literature DB >> 7066054

Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis.

E Z Katz, M Ehrenfeld, M Levy, M Eliakim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7066054     DOI： 10.1002/art.1780250219

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.

Authors:  G Achtert; J M Scherrmann; M O Christen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

2.  Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?

Authors:  Hakan Emmungil; Ufuk İlgen; Sezin Turan; Samet Yaman; Orhan Küçükşahin
Journal:  Rheumatol Int       Date:  2019-08-28       Impact factor: 2.631

3.  The effect of long-term colchicine therapy in patients with recurrent polyserositis on the capacity of blood platelets to synthesize thromboxane A2.

Authors:  M Levy; A Eldor; E Zylber-Katz; M Eliakim
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

4.  Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial mediterranean fever).

Authors:  M Ehrenfeld; M Levy; P Sharon; D Rachmilewitz; M Eliakim
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

5.  Colchicine concentration in leukocytes of patients with familial Mediterranean fever.

Authors:  O Chappey; E Niel; M Dervichian; J L Wautier; J M Scherrmann; D Cattan
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.